Evidence map›Paper›PMID 42534744›Full record

ArticleFrontiers in cell and developmental biology2026

5-ALA/Fe

Jiewen Zhu, Jing Zhai, Zhanxin Xu, Yifan Wang, Jinle Xie, Yangyun Wang, Jiangang Hou, Ke Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiewen Zhu *Department of Urology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Jing Zhai *Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Zhanxin XuDepartment of Urology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Yifan WangDepartment of Urology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Jinle XieDepartment of Pelvic Floor Center, Shanghai Fifth People's Hospital Affiliated to Fudan University, Minhang District Pelvic Floor Center, Shanghai, China.
Yangyun WangDepartment of Urology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Jiangang HouDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Ke XuDepartment of Urology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-obstructive azoospermia (NOA) remains a major challenge in the management of male infertility, with currently limited effective therapeutic options available. The study investigates the therapeutic potential and underlying mechanism of 5-aminolevulinic acid with ferrous iron (5-ALA/Fe Methods: A busulfan-induced NOA mouse model was established and treated with low or high-dose 5-ALA/Fe Results: 5-ALA/Fe Conclusion: Our findings demonstrate that 5-ALA/Fe

Indexed as

5-alaapoptosisbusulfanCaspase3non-obstructive azoospermiaTP53

Identifiers

PMID42534744
PMCPMC13422210

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.